Hillenbrand posts tiny Q3 profit; revenue, adjusted EBITDA fall as TerraSource sale boosts liquidity

Hillenbrand (NYSE: HI) - quick take

What's happening inside: management completed the Milacron divestiture (Mar 31, 2025), retained a 48.74% equity stake, and recorded a loss on the transaction. Results for the quarter improved versus heavy one‑time charges in FY24 (no repeat goodwill/indefinite‑lived impairments in 2025), but organic volumes are down and the company used operating cash in the nine months. Post‑period the company completed a major credit amendment (July 2025) and closed the TerraSource sale (July 1, 2025) that should produce a reported pre‑tax gain (~$66M) subject to adjustments.

Key points & stats (as reported for period ended June 30, 2025)
* Net revenue - Q3 (three months): $598.9M vs $786.6M a year ago (‑24%).
* Net revenue - YTD (nine months): $2,021.7M vs $2,345.2M a year ago (‑14%).
* Gross profit - Q3: $202.6M (margin 33.8%). YTD: $674.0M (33.3%).
* Consolidated net income - Q3: $4.1M; Net income attributable to Hillenbrand Q3: $1.9M (EPS $0.03 basic/diluted).
* Consolidated net loss - YTD: $(25.6)M; Net loss attributable to Hillenbrand YTD: $(32.6)M (EPS $(0.46)).
* Adjusted EBITDA - Q3: $84.3M (vs $131.0M prior year). YTD: $280.1M (vs $367.8M prior year).
* Loss on divestiture (Milacron) - Q3: $1.5M; YTD: $56.1M (after post‑closing adjustments).
* Prior‑year impairment (nonrecurring) - $265.0M in 2024 (did not recur in 2025).
* Interest expense, net - Q3: $21.3M (down from $32.2M); YTD: $69.6M (down from $92.8M).
* Cash & cash equivalents - $162.8M (June 30, 2025). Total cash, cash equivalents and restricted cash (CF) - $190.0M.
* Total assets - $4,676.5M (down from $5,238.7M at 9/30/24). Total liabilities - $3,324.3M. Shareholders' equity - $1,352.2M.
* Total debt (carrying) - $1,676.2M; Total long‑term debt - $1,663.6M (June 30, 2025).
* Inventories - $386.2M (down from $525.2M). Trade receivables, net - $291.7M. Receivables from long‑term contracts - $288.5M.
* Backlog / remaining performance obligations - $1,624.2 (approx. 75% expected to be satisfied in next 12 months).
* Shares outstanding - ~70.48M (Aug 1, 2025). Quarterly dividend - $0.225/share in 2025. YTD dividends paid - $47.5M.

Positive income‑statement and corporate developments
* No repeat of the large goodwill/indefinite‑lived impairment that drove FY24 losses - removes a major nonrecurring drag and clarifies underlying performance.
* Q3 GAAP net income turned positive (small) and EPS recovered to $0.03 vs a large loss a year ago - demonstrates earnings volatility has moderated without the FY24 impairment.
* Interest expense materially lower versus prior year (Q3 down ~34% and YTD down ~25%), reflecting deleveraging and refinancing activity.
* Improved gross‑profit margins in some segments (Molding Technology Solutions margin expanded vs prior year after restructuring/productivity gains).
* Executed strategic divestitures (Milacron; TerraSource sold post‑period) that generate cash proceeds and simplify the portfolio - TerraSource expected pre‑tax gain ~ $66M (subject to adjustments).

Negative income‑statement and operational headwinds
* Revenue decline driven by divestiture of Milacron and weaker volumes across Advanced Process Solutions: Q3 revenue down 24% YoY; YTD down 14%.
* Adjusted EBITDA down Q3 (‑36%) and YTD (‑24%) - core operating profitability under pressure from lower volumes, cost inflation and mix.
* SG&A as a percent of revenue increased (Q3 SG&A 24.4% of revenue, +230 bps YoY) - fixed costs spread over lower sales and elevated integration/restructuring costs.
* Operating cash flow used $11.5M YTD (compared with $24.8M provided prior year) - working capital timing and lower advance billings increased cash consumption.
* Income tax volatility - Q3 effective tax rate 61.3% (vs 4.1% prior year); YTD effective tax rate (39.1%) driven by non‑recurring items and geographic mix - tax noise may continue while divestiture tax effects are finalized.
* Leverage remains meaningful: long‑term debt ~$1.66B and total debt ~$1.68B; company continues to refinance and amend credit (new $700M revolver / $175M term loan and €240 delayed draw facility signed July 2025) - covenant relief and diligence needed by investors.

What to watch next (near term catalysts & risks)
* Realized cash impact and accounting gain from TerraSource sale (closed July 1, 2025) - improves liquidity and may materially reduce net debt after post‑closing adjustments.
* Execution on margin recovery in Advanced Process Solutions: volume, pricing, productivity and cost‑inflation management will determine adjusted EBITDA trajectory.
* Backlog conversion and order intake trends - APS backlog ~$1,569.6M (down 10% YoY); Molding backlog collapsed after Milacron divestiture - watch new orders and international demand.
* Debt metrics and covenant headroom under the July 2025 Credit Agreement (leverage test schedule) - monitor leverage ratio and free cash flow to assess deleveraging.
* Working capital and operating cash flow - company used cash YTD; stabilization needed to restore comfortable liquidity without asset sales.

Bottom line: Hillenbrand has cleaned up the balance sheet risk from the large FY24 impairment and is reshaping the portfolio through divestitures. That reduces one‑time volatility and provides cash (TerraSource). But organic revenue and adjusted EBITDA are down, operating cash flow turned negative YTD, and leverage remains elevated. Investors should focus on order intake/backlog trends, cash conversion, and how the company uses proceeds (debt paydown vs. shareholder returns) as proof that operating results can recover sustainably.